These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. Maiques-Diaz A; Chou FS; Wunderlich M; Gómez-López G; Jacinto FV; Rodriguez-Perales S; Larrayoz MJ; Calasanz MJ; Mulloy JC; Cigudosa JC; Alvarez S Leukemia; 2012 Jun; 26(6):1329-37. PubMed ID: 22289984 [TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547 [TBL] [Abstract][Full Text] [Related]
25. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288 [TBL] [Abstract][Full Text] [Related]
26. Runx1t1 (Runt-related transcription factor 1; translocated to, 1) epigenetically regulates the proliferation and nitric oxide production of microglia. Baby N; Li Y; Ling EA; Lu J; Dheen ST PLoS One; 2014; 9(2):e89326. PubMed ID: 24586690 [TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC. Shukla V; Wang H; Varticovski L; Baek S; Wang R; Wu X; Echtenkamp F; Villa-Hernandez F; Prothro KP; Gara SK; Zhang MR; Shiffka S; Raziuddin R; Neckers LM; Linehan WM; Chen H; Hager GL; Schrump DS J Thorac Oncol; 2024 Aug; 19(8):1201-1217. PubMed ID: 38583771 [TBL] [Abstract][Full Text] [Related]
28. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Kalari S; Jung M; Kernstine KH; Takahashi T; Pfeifer GP Oncogene; 2013 Jul; 32(30):3559-68. PubMed ID: 22907430 [TBL] [Abstract][Full Text] [Related]
29. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML. Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112 [TBL] [Abstract][Full Text] [Related]
30. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia. Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494 [TBL] [Abstract][Full Text] [Related]
31. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia. Yang E; Guan W; Gong D; Gao X; Han C; Zhang J; Wang H; Wang M; Li Y; Yu L Clin Sci (Lond); 2020 Dec; 134(23):3079-3091. PubMed ID: 33201243 [TBL] [Abstract][Full Text] [Related]
33. Ectopic expression of the CDK inhibitor p21 Kurayoshi K; Shiromoto A; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K Biochem Biophys Res Commun; 2017 Jan; 483(1):107-114. PubMed ID: 28042030 [TBL] [Abstract][Full Text] [Related]
35. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540 [TBL] [Abstract][Full Text] [Related]
37. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells. Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849 [TBL] [Abstract][Full Text] [Related]
38. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Luszczek W; Cheriyath V; Mekhail TM; Borden EC Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643 [TBL] [Abstract][Full Text] [Related]
39. Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. Chiba T; Yokosuka O; Arai M; Tada M; Fukai K; Imazeki F; Kato M; Seki N; Saisho H J Hepatol; 2004 Sep; 41(3):436-45. PubMed ID: 15336447 [TBL] [Abstract][Full Text] [Related]
40. Survivin expression impacts prognostically on NSCLC but not SCLC. Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]